MedPath

RIVA-LORAZEPAM 2MG TABLETS

RIVA-LORAZEPAM 2MG TABLETS

Discontinued
DIN Number

02240727

Drug Class

Human

Market Date

Aug 26, 1999

Company
HC

laboratoire riva inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02240727
AIG Number0110731002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA06 LORAZEPAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

LORAZEPAMActive
Strength: 2 MG / TAB
Monograph: LORAZEPAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.